Videos de Experimentos Relacionados
El progreso en la investigación de la esclerosis sistémica.
1Department of Medicine, Division of Rheumatology, Medical College of Ohio, Toledo, OH 43614, USA. bkahaleh@mco.edu
Lancet (London, England)
|August 18, 2004
Resumen
No abstract available in PubMed .
Videos de Conceptos Relacionados
También podría leer
Artículos Relacionados
Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.
Ordenar por
Same author
Editorial Expression of Concern: A model of anti-angiogenesis: differential transcriptosome profiling of microvascular endothelial cells from diffuse systemic sclerosis patients.
Arthritis research & therapy·2025
Same author
Decreased prevalence and altered clinical phenotype of systemic sclerosis and other autoimmune connective tissue diseases in type 1 and type 2 diabetes: A cross-sectional observational study.
Journal of scleroderma and related disorders·2024
Same author
Myocarditis in connective tissue diseases: an often-overlooked clinical manifestation.
Rheumatology international·2023
Same author
Expert consensus on the management of systemic sclerosis-associated interstitial lung disease.
Respiratory research·2023
Same author
Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive disease.
Rheumatology (Oxford, England)·2022
Same journal
Assisted dying and the silencing of medicine's next generation.
Lancet (London, England)·2026
Same journal
Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.
Lancet (London, England)·2026
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)·2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)·2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)·2026